Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial
Journal of Retina-Vitreous · 2026 · 35 (2) · 145
DOI: 10.37845/ret.vit.2026.35.19 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Retina-Vitreous, 2026. Verfasst von Ari Djatikusumo und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Djatikusumo, A., Victor, A. A., Nora, R. L. D., Wibowo, H., & Ardhia, S. H. (2026). Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial. Journal of Retina-Vitreous, 35(2), 145. https://doi.org/10.37845/ret.vit.2026.35.19
Vancouver
Djatikusumo A, Victor AA, Nora RLD, Wibowo H, Ardhia SH. Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial. Journal of Retina-Vitreous. 2026;35(2):145. doi:10.37845/ret.vit.2026.35.19
BibTeX
@article{Djatikusumo2026,
author = {Djatikusumo, Ari and Victor, Andi Arus and Nora, Rina La Distia and Wibowo, Heri and Ardhia, Seruni Hanna},
title = {Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial},
journal = {Journal of Retina-Vitreous},
year = {2026},
volume = {35},
number = {2},
pages = {145},
doi = {10.37845/ret.vit.2026.35.19}
}
EUVIMED